Australian biotech market today 06.05.09
Wednesday, 06 May, 2009
A very flat day’s trading today at 1.30pm, with the healthcare index down slightly along with the rest of the All Ordinaries.
The biotech majors (COH, CSL, RMD) regained some lost ground from yesterday, while Pharmaxis (ASX:PXS) is down a little after yesterday’s gains.
Novogen (ASX:NRT) is up a cent to 46c.
Singapore company SciGen (ASX:SIE) has told the ASX it is unaware of any reason why its stocks are experiencing turbulence at the moment – high volumes have been traded although the share price remains a tiny 12c.
The company appointed a new CEO and chairman a fortnight ago, with founder Saul Mashaal standing down.
Inhaled form of blood thinner treats serious COVID infections
Heparin has traditionally been injected and used to treat blood clots, but the new study tested...
Next-gen therapies could treat high-grade gliomas
Government funding will enable researchers to test a suite of next-generation therapies they have...
Bacteriophage cocktail to combat superbugs
Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...
